Abstract
Respective mean values of the serum concentrations autosomal dominant polycystic kidney disease in two. Forty of PG I and PG II, and the PG I/PG II ratio were one of the patients were on haemodialysis (HD), and eight 277.4±24.2 pg/ml, 30.2±2.9 pg/ml and 9.2±0.7 in the were on continuous ambulatory peritoneal dialysis (CAPD). dialysis patients, and 52.6±4.0 pg/ml, 14.9±1.3 pg/ml The mean duration of dialysis was 29.3±5.4 months. Forty and 3.5±0.3 in the controls. All of these parameters eight other patients who had no kidney disease were used as were elevated significantly in the dialysis patients comcontrols: 25 males and 23 females, mean age 48.6±1.6 years. pared with the controls (P<0.01).
The mean age of the controls did not differ statistically from Serum concentrations of PG I and PG II and mean that of the patients on dialysis.
PG I/PG II ratios in terms of H. pylori status are All subjects including the controls were referred for upper gastroduodenal endoscopy to investigate their gastrointesti-presented in Table 1 . The H. pylori-positive dialysis nal symptoms and signs. These included nausea, abdominal patients had a higher PG I level than their H. pyloripain, heartburn, anorexia, anaemia, occult blood in the negative counterparts. Among the subjects with stools, etc. Patients who were treated with H 2 -blockers or H. pylori infection, those on dialysis had significantly proton-pump inhibitors 2 weeks prior to the endoscopic higher concentrations of PG I than the controls. This examination or who took antibiotics 4 weeks prior to the was also the case among the subjects without H. pylori endoscopy were excluded. Informed consent was obtained infection. The serum PG II concentrations in subjects from all of the subjects.
with H. pylori infection were significantly higher than in those without infection in both dialysis patients and 
PG I/PG II ratios in dialysis patients treated by
Prior to endoscopic examination, venous blood was drawn, different dialysis methods are shown in Table 2 . The and the serum concentrations of PG I and PG II were measured by radioimmunoassay (Dainabot, Tokyo, Japan) values in patients on a HD and those on CAPD were [13] . The normal ranges with this test kit are 15-100 pg/ml comparable between the H. pylori-positive and for PG I, and 3-40 pg/ml for PG II.
-negative groups. The PG I/PG II ratios of the patients who showed Statistical analyses endoscopic atrophic gastritis are presented in Figure 1 . Dialysis patients in this group showed significantly Results are expressed as mean±SEM. Analysis of variance higher ratios than the controls: 9.2±2.2 and 3.5±0.7, was used to compare the serum concentrations of PG I and respectively, P<0.01. Among the controls, 15 of 25 PG II as well as the ratio of PG I and PG II. The unpaired subjects (60.0%) with atrophic gastritis showed PG t-test was used to compare the mean ages of patients on I/PG II ratios ∏3.0, but only two of 17 patients on dialysis with those of the controls. Comparisons of propor-dialysis fell into this range (11.8%, P<0.01 compared tions between the two groups were tested by Fisher's exact with the controls).
test. A probability of <0.05 was considered significant.
Results Discussion
The present study showed serum concentrations of PG Helicobacter pylori was identified in 25 of 49 patients on dialysis (51.0%), and in 26 of the 48 control subjects I and PG II to be significantly elevated in dialysis patients when compared with controls. Our findings (54.2%). Gastroduodenal lesions in dialysis patients were determined to be erosive gastritis in 21 patients, agree with the previous reports in patients with chronic renal failure [2,6-8]. Among dialysis patients, those atrophic gastritis in 17, gastric ulcer in four, superficial gastritis in three, duodenitis in two, and duodenal ulcer infected with H. pylori had higher serum PG II concentrations and lower PG I/PG II ratios than those who in one; a normal gastric mucosa was seen in one patient. Among the control subjects, 25 lesions were were not infected with this bacterium. The same pattern has been shown in asymptomatic healthy subjects [9] . identified as atrophic gastritis, six as erosive gastritis, five as superficial gastritis, three as gastric ulcer, two To our knowledge, however, the present study is the first examining the effects of H. pylori infection on the as duodenal ulcer, and two as gastric cancer; five subjects had normal gastric mucosa. serum pepsinogens in dialysis patients. lytic activity; and hyperpepsinogenaemia is a risk factor for peptic ulcer diseases. Until now, however, correlation between serum pepsinogen levels and gastroduodenal lesions, or the influence of hyperpepsinogenaemia on gastric acid secretory function has not been studied for dialysis patients. Moreover, multiple factors appear to contribute to gastritis as well as peptic ulcer diseases in patients with chronic renal failure [14] . Therefore, the pathogenetic implication of hyperpepsinogenaemia in gastroduodenal lesions, if any, remains to be defined in dialysis patients. Although the mechanism by which H. pylori infection produces hyperpepsinogenaemia remains unknown, it has been suggested that inflammation of the gastric mucosa induced by H. pylori may increase leakage of pepsinogens into the systemic circulation [15] . Dialysis patients with H. pylori infection, on the other hand, have elevated concentrations of serum gastrin [11, 12] . We have shown recently that dialysis patients infected with H. pylori had significantly higher concentrations of serum gastrin than those who were [16 ]. Therefore, it seems possible that the hypergastrinaemia seen in dialysis patients is attributable to H. pylori infection of the stomach, rather than a loss In the general population, participation of serum of renal function or gastric atrophy. Gastrin possesses pepsinogens in gastroduodenal disorders has been sug-a trophic action on gastric mucosal cells [17] , leading gested by the following observations [1]: serum pep-to an increase in chief cell mass. Gastrin also stimulates sinogen levels reflect secretory cell mass of the gastric pepsinogen secretion from gastric chief cells by increasmucosa; pepsinogens secreted into the gastric lumen ing the free cytoplasmic calcium concentration [18] . Accordingly, we speculate that serum pepsinogens can are converted to pepsins which possess a potent proteo-
